Detalles de la búsqueda
1.
Long or complicated mpox in patients with uncontrolled HIV infection.
J Med Virol
; 96(3): e29511, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38469884
2.
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice.
J Antimicrob Chemother
; 78(10): 2591-2596, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37671831
3.
Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response.
Clin Infect Dis
; 72(5): e96-e102, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211801
4.
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.
J Hepatol
; 74(4): 801-810, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33220331
5.
Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy.
J Viral Hepat
; 28(6): 878-886, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721377
6.
What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis.
BMC Infect Dis
; 20(1): 588, 2020 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770955
7.
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy.
J Hepatol
; 71(1): 45-51, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30853642
8.
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world.
J Hepatol
; 71(5): 876-888, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279901
9.
Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection.
J Viral Hepat
; 26(1): 16-24, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30141222
10.
Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients.
J Viral Hepat
; 26(1): 48-54, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30199593
11.
A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study).
Liver Int
; 39(10): 1918-1926, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31206233
12.
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis.
J Antimicrob Chemother
; 73(9): 2435-2443, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29982683
13.
Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
Clin Infect Dis
; 65(6): 1012-1019, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28903510
14.
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Hepatology
; 61(5): 1503-11, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25545020
15.
No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014.
BMC Infect Dis
; 16: 489, 2016 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27634297
16.
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.
BMC Infect Dis
; 15: 557, 2015 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26643257
17.
A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.
Clin Infect Dis
; 58(1): 130-3, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24065317
18.
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.
Clin Infect Dis
; 56(11): 1646-53, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23429381
19.
Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.
Clin Infect Dis
; 57(10): 1401-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23946224
20.
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Hepatology
; 56(1): 228-38, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22278746